Therapeutic controversy: Obesity--a modern-day epidemic. Academic Article uri icon

Overview

abstract

  • While the hyperleptinemia of obesity is likely to be associated with the metabolic complications of obesity/hyperinsulinemia/insulin resistance, it is not associated with diabetes, with the relative hypercortisolism of upper body obesity, with hypertension in women, (it is in men), or with dyslipidemia. Overall, the correlations between leptin and the metabolic diseases associated with obesity are weak. The equivocal results of an association of leptin with components of the metabolic syndrome make it unlikely that leptin affects these directly. (On the other hand, these correlations, when found, preclude any causal relationship between leptin and metabolic diseases.) There are experimental data showing a definite role for insulin and glucocorticoids in the regulation of leptin, and of leptin in the regulation of insulin. More data are required on the effects of leptin, but it is likely that leptin will not be a major link between obesity and the metabolic syndrome. Certainly, however, when leptin is available for clinical use, its effect on different aspects of the metabolic syndrome will be worth studying.

publication date

  • January 1, 1999

Research

keywords

  • Obesity

Identity

Scopus Document Identifier

  • 0032937163

Digital Object Identifier (DOI)

  • 10.1210/jcem.84.1.5392-1

PubMed ID

  • 9920054

Additional Document Info

volume

  • 84

issue

  • 1